Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
NeuroVax (IR902) / Immune Response BioPharma
NCT02057159 / 2006-003384-30: A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis	Recruiting	2/3	200	US	NeuroVax, IFA Placebo	Immune Response BioPharma, Inc., cro	Secondary Progress Multiple Sclerosis, Multiple Sclerosis	03/23	03/23
NCT02200718: A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis	Not yet recruiting	1	12	US	NeuroVax, IR902 TCR Peptide Formulation in IFA BV5S2, BV6S5 BV13S1, IFA Incomplete Freund's Adjuvant	Immune Response BioPharma, Inc.	Multiple Sclerosis	11/24	11/24